Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epilepsy drives autism in neurodevelopmental disorders.

Literature DB >> 23320573

Epilepsy drives autism in neurodevelopmental disorders.

Randi J Hagerman¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23320573 PMCID： PMC4051495 DOI： 10.1111/dmcn.12071

Source DB: PubMed Journal: Dev Med Child Neurol ISSN： 0012-1622 Impact factor: 5.449

× No keyword cloud information.

12 in total

1. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.

Authors: Weerasak Chonchaiya; Jacky Au; Andrea Schneider; David Hessl; Susan W Harris; Meredith Laird; Yi Mu; Flora Tassone; Danh V Nguyen; Randi J Hagerman
Journal: Hum Genet Date: 2011-10-15 Impact factor: 4.132

2. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.

Authors: Sébastien Jacquemont; Aurore Curie; Vincent des Portes; Maria Giulia Torrioli; Elizabeth Berry-Kravis; Randi J Hagerman; Feliciano J Ramos; Kim Cornish; Yunsheng He; Charles Paulding; Giovanni Neri; Fei Chen; Nouchine Hadjikhani; Danielle Martinet; Joanne Meyer; Jacques S Beckmann; Karine Delange; Amandine Brun; Gerald Bussy; Fabrizio Gasparini; Talita Hilse; Annette Floesser; Janice Branson; Graeme Bilbe; Donald Johns; Baltazar Gomez-Mancilla
Journal: Sci Transl Med Date: 2011-01-05 Impact factor: 17.956

Review 3. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis.

Authors: Irfan A Qureshi; Mark F Mehler
Journal: Neurobiol Dis Date: 2010-02-24 Impact factor: 5.996

4. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.

Authors: Elizabeth M Berry-Kravis; David Hessl; Barbara Rathmell; Peter Zarevics; Maryann Cherubini; Karen Walton-Bowen; Yi Mu; Danh V Nguyen; Joseph Gonzalez-Heydrich; Paul P Wang; Randall L Carpenter; Mark F Bear; Randi J Hagerman
Journal: Sci Transl Med Date: 2012-09-19 Impact factor: 17.956

5. De novo gene disruptions in children on the autistic spectrum.

Authors: Ivan Iossifov; Michael Ronemus; Dan Levy; Zihua Wang; Inessa Hakker; Julie Rosenbaum; Boris Yamrom; Yoon-Ha Lee; Giuseppe Narzisi; Anthony Leotta; Jude Kendall; Ewa Grabowska; Beicong Ma; Steven Marks; Linda Rodgers; Asya Stepansky; Jennifer Troge; Peter Andrews; Mitchell Bekritsky; Kith Pradhan; Elena Ghiban; Melissa Kramer; Jennifer Parla; Ryan Demeter; Lucinda L Fulton; Robert S Fulton; Vincent J Magrini; Kenny Ye; Jennifer C Darnell; Robert B Darnell; Elaine R Mardis; Richard K Wilson; Michael C Schatz; W Richard McCombie; Michael Wigler
Journal: Neuron Date: 2012-04-26 Impact factor: 17.173

Review 6. The role of fragile X mental retardation protein in major mental disorders.

Authors: S Hossein Fatemi; Timothy D Folsom
Journal: Neuropharmacology Date: 2010-11-22 Impact factor: 5.250

7. Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.

Authors: Agnies M van Eeghen; Margaret B Pulsifer; Vanessa L Merker; Ann M Neumeyer; Elmer E van Eeghen; Ronald L Thibert; Andrew J Cole; Fawn A Leigh; Scott R Plotkin; Elizabeth A Thiele
Journal: Dev Med Child Neurol Date: 2012-12-04 Impact factor: 5.449

8. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration.

Authors: Yucui Chen; Flora Tassone; Robert F Berman; Paul J Hagerman; Randi J Hagerman; Rob Willemsen; Isaac N Pessah
Journal: Hum Mol Genet Date: 2010-01-01 Impact factor: 6.150

9. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.

Authors: T V Bilousova; L Dansie; M Ngo; J Aye; J R Charles; D W Ethell; I M Ethell
Journal: J Med Genet Date: 2008-10-03 Impact factor: 6.318

10. Important role of matrix metalloproteinase 9 in epileptogenesis.

Authors: Grzegorz M Wilczynski; Filip A Konopacki; Ewa Wilczek; Zofia Lasiecka; Adam Gorlewicz; Piotr Michaluk; Marcin Wawrzyniak; Monika Malinowska; Pawel Okulski; Lukasz R Kolodziej; Witold Konopka; Kamila Duniec; Barbara Mioduszewska; Evgeni Nikolaev; Agnieszka Walczak; Dorota Owczarek; Dariusz C Gorecki; Werner Zuschratter; Ole Petter Ottersen; Leszek Kaczmarek
Journal: J Cell Biol Date: 2008-03-10 Impact factor: 10.539

5 in total

Epilepsy drives autism in neurodevelopmental disorders.

1. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.

2. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.

Review 3. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis.

4. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.

5. De novo gene disruptions in children on the autistic spectrum.

Review 6. The role of fragile X mental retardation protein in major mental disorders.

7. Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.

8. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration.

9. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.

10. Important role of matrix metalloproteinase 9 in epileptogenesis.

1. Preclinical testing of the ketogenic diet in fragile X mice.

2. The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy.

Review 3. A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensity.

Review 4. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.

5. Effect of epilepsy on autism symptoms in Angelman syndrome.